- DKK547.10m
- DKK499.72m
- DKK40.29m
Brief: Bioporto A/S Says Henrik Juuel Appointed Interim Chairman Of Bioporto Board
Brief: Bioporto Preliminary Financial Figures for 2024
Brief: Bioporto A/S Says Chair John Mcdonough To Resign By Next Annual Meeting
Brief: BioPorto Q3 Adjusted EBITDA DKK -19.6 Million
Brief: Bioporto Enters Global Distribution Partnership With Beckman Coulter
Europe Research Roundup: Henkel AG, Rio Tinto, Rockwool A/S
Brief: Bioporto Maintains Guidance For 2024
Brief: BioPorto Q2 Adjusted EBITDA DKK -16.2 Million
Brief: Bioporto Gets Gross Proceeds Of DKK 81.4 Mln From Oversubscribed Private Placement
Brief: Bioporto Says Initiates Private Placement Of 50 Mln New Shares At Market Price
Brief: Bioporto Appoints Niels Høy Nielsen As CFO
Brief: BioPorto Q1 Adjusted EBITDA DKK -15.3 Million
Brief: Peter Mørch Eriksen Appointed Permanent Group CEO Of BioPorto
Brief: Bioporto Announces Preliminary Results For 2023
Brief: BioPorto Outlook FY Adjusted EBITDA DKK -90 to -75 Million
Brief: Bioporto, Roche Diagnostics Expand Existing Global Distribution Deal
Brief: Bioporto Says CEO Anthony Pare to Step Down
Brief: Bioporto Says Receives FDA 510(K) Clearance For NGAL Test In United States First Test To Aid In Assessing AKI Risk For Patients Aged 3 Months Through 21 Years
Brief: Bioporto Announces Interim Results And Business Update For Q3